Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be th... Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0118 | 1.77203784352 | 0.6659 | 0.6898 | 0.582 | 1335180 | 0.62776671 | CS |
4 | -0.0223 | -3.18571428571 | 0.7 | 0.7394 | 0.582 | 1468900 | 0.65209223 | CS |
12 | 0.0675 | 11.0619469027 | 0.6102 | 0.98 | 0.5451 | 2211761 | 0.69809252 | CS |
26 | -0.0845 | -11.0863290475 | 0.7622 | 0.98 | 0.5 | 1374430 | 0.67516638 | CS |
52 | -2.2123 | -76.5501730104 | 2.89 | 5.8299 | 0.5 | 1209262 | 1.67163986 | CS |
156 | -3.0923 | -82.023872679 | 3.77 | 5.89 | 0.363 | 920864 | 2.26409226 | CS |
260 | -13.3223 | -95.1592857143 | 14 | 16.22 | 0.363 | 771425 | 2.36622388 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions